Skip to main content
JHXJames Hardie Industries plc.Sell5.1·$26.39+2.21%
JHX · Why this verdict

Why James Hardie Industries (JHX) is rated SELL

Updated

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

VerdictSELL
Overall score5.1/10
ConfidenceMEDIUM
MacroNEUTRAL
TrendMatrix Research · core thesis

Engine thesis — one sentence

James Hardie combines industry-leading revenue growth of 44% with exceptional free cash flow conversion at 356% of net income and a Piotroski score of 8 out of 9, but the stock trades above its near-term target at overbought levels with an extreme options put/call ratio of 17.33 and a high-concentration supplier dependency.

Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.

Thesis pillars

Dependence on a single capped-compounds supplier is flagged as a high-concentration risk in the company's own risk disclosures, creating vulnerability to supply disruption or pricing pressure that could impair margins and production volumes.

Stable
Bear case
Expectation
The company discloses sourcing from at least 2 qualified compound suppliers within the next 12 months, reducing single-source dependency.

CounterThe company's Piotroski score of 8 out of 9 and strong historical cash conversion suggest this supplier relationship has been managed effectively; the risk is real but may be partially offset by existing contractual protections.

With RSI at 71 and the price trading above the near-term target, the stock is technically extended; the risk/reward is unfavorable for new capital at this level, and an extreme put/call ratio of 17.33 signals substantial options market hedging activity.

Stable
Momentum breakdown
Expectation
RSI cools below 55 and price pulls back below the near-term resistance level within two quarters, creating a more attractive entry point.

CounterIn high-growth building materials businesses, overbought momentum readings can persist alongside volume accumulation for an extended period; selling into strong price action risks missing the next advance if revenue growth sustains above 20%.

Revenue grew 44% year-over-year, positioning the company as the growth leader within its peer group in building materials, with volume accumulation confirming demand for the shares alongside the business.

Stable
Growth breakdown
Expectation
Revenue growth remains above 20% year-over-year for the next two quarters, sustaining the growth-leader positioning.

CounterReliance on a single capped-compounds supplier represents a high-concentration supply-chain risk; any disruption to that source could impair production and derail the revenue trajectory materially.

Free cash flow is running at 356% of reported net income, indicating the business generates substantially more cash than accounting earnings suggest and providing financial flexibility well beyond what the income statement shows.

Stable
Quality breakdown
Expectation
Free cash flow remains above 150% of reported net income for the next four quarters, sustaining the quality of the cash generation profile.

CounterA gap this wide between free cash flow and net income warrants scrutiny; if the accounting treatments or one-time items driving the disparity normalize, the apparent cash conversion advantage could shrink sharply.

Per-dimension breakdown

Value

5.0/10data confidence 100%
ComponentSub-score
P/E0.0
P/S8.2
EV/EBITDA2.6
Fwd P/E8.0
PEG6.0
Analyst target4.0
  • Forward P/E: 15.0x
  • PEG: 1.24

Quality

5.3/10data confidence 100%
ComponentSub-score
ROE0.8
ROA3.4
Gross margin3.4
Op margin7.6
Net margin1.1
Current ratio5.7
FCF quality10.0
Moat6.4
Piotroski F8.9
  • Excellent cash conversion: 356% FCF/NI
  • Strong Piotroski F-Score: 8/9

Growth

5.0/10data confidence 67%
ComponentSub-score
Rev growth10.0
EPS growth0.0
  • Strong growth: 44% YoY

Momentum

4.8/10data confidence 100%
ComponentSub-score
RSI5.0
MACD9.8
OBV1.0
MA position8.0
Volume0.0
  • Volume distribution (falling OBV)
  • Above 200-MA but MA slope flat

Sentiment

6.5/10data confidence 100%
ComponentSub-score
Analyst rating7.7
Price target6.1
erm sentiment5.0
  • Light analyst coverage (7.0) — signal dampened

Insider

5.0/10data confidence 50%
ComponentSub-score
materiality5.0
holder change5.1
  • Negligible insider buying — $68,730 (0.000% of mkt cap)

Peer rank

4.0/10data confidence 80%
ComponentSub-score
value rank1.7
quality rank0.0
growth rank9.2
  • Industry growth leader

Technical

2.7/10data confidence 100%
ComponentSub-score
bollinger0.0
support resistance0.4
52w position7.8

Risk (lower is worse)

6.0/10data confidence 100%
ComponentSub-score
days to cover7.0
volatility2.0
put call10.0
implied vol4.1
beta6.8
debt equity6.4
  • Concentration risks: 1 HIGH (10-K Item 1A — sized via position_sizing, validated via buy_confidence)

Catalyst

6.1/10data confidence 100%
ComponentSub-score
erm5.0
earnings history10.0
earnings timing5.0
surprise avg4.4

How the verdict was assembled

Engine trigger

Multiple concerning factors. Consider reducing position.

Engine technical detail
verdict_path: L4:PATH_F_SELL
Passed (6)
  • MOMENTUM:4.8>=4.5
  • INSIDER:OK
  • NEWS_EVENTS:NONE_RECENT
  • EARNINGS_PROXIMITY:54d clear
  • SEMI_CYCLE_PEAK:CLEAR
  • MATERIALS_CYCLE_PEAK:CLEAR
Failed (1)
  • ASYMMETRY:-0.4=NEGATIVE
Warning (2)
  • MOMENTUM:4.8<5.5 (soft — BUY_NOW allowed but watch)
  • 8K_CSUITE_CHANGE:5.02 (officer departure/appointment)
Reward-to-Risk
-0.44
Upside
-6.6%
Downside
15.0%
Sizing output
AVOID

SetupBREAKOUT Golden cross, above all MAs, RSI 65, MACD bullish

EdgeNO_EDGE No clear edge identified

SuitabilityMODERATE Balanced profile

Investment implication

The F-path SELL output reflects an overall score of 5.1 below the 5.6 soft trigger — multiple weakening dimensions accumulated rather than a single hard-floor breach. The strongest dimension ( Sentiment at 6.5) was not enough to lift the adjusted overall above the threshold. Co-occurring failed gates ( ASYMMETRY:-0.4=NEGATIVE) reinforce the read. Current asymmetry R:R is -0.44 — supplementary context, not the trigger for this path.

The strongest dimensions are Sentiment at 6.5, Catalyst at 6.1, and Risk (lower is worse) at 6.0; the weakest are Technical at 2.7, Peer rank at 4.0, and Momentum at 4.8. The V9 engine flagged 1 failed gate with 2 warnings, producing an asymmetric reward-to-risk of -0.44 and an engine sizing output of AVOID.

What would invalidate the thesis

Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.

  • P1Revenue grew 44% year-over-year, positioning the company as the growth leader within its peer group in building materials, with volume accumulation confirming demand for the shares alongside the business.

    Trip ifRevenue growth falls below 10% year-over-year for 2 consecutive quarters.

  • P2Free cash flow is running at 356% of reported net income, indicating the business generates substantially more cash than accounting earnings suggest and providing financial flexibility well beyond what the income statement shows.

    Trip ifFree cash flow falls below 100% of reported net income for 2 consecutive quarters.

  • P3With RSI at 71 and the price trading above the near-term target, the stock is technically extended; the risk/reward is unfavorable for new capital at this level, and an extreme put/call ratio of 17.33 signals substantial options market hedging activity.

    Trip ifPrice rises more than 15% above current levels while RSI sustains above 70 for 4 consecutive weeks, demonstrating the overbought condition resolved by continued advance rather than consolidation.

  • P4Dependence on a single capped-compounds supplier is flagged as a high-concentration risk in the company's own risk disclosures, creating vulnerability to supply disruption or pricing pressure that could impair margins and production volumes.

    Trip ifCompany discloses qualified compound sourcing from at least 2 independent suppliers, reducing single-source dependency.

Engine reasoning is mechanically derived from pipeline gate outputs. See decision view.

Home Stocks JHX Why this verdict